Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
Conditions: Acute Myeloid Leukemia Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Hospitals | Learning | Leukemia | Research | Universities & Medical Training